Chutko L S, Surushkina S Iu, Nikishena I S, Iakovenko E A, Anisimova T I, Sergeev A V
Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(8):45-8.
Effectiveness of adaptol, a non-benzodiazepine tranquilizer, in the treatment of ADHD has been studied. The use of adaptol in dosage 500 mg 2 times daily during one month resulted in the decrease of hyperactivity and impulsivity and did not exert any influence on attention and reaction time. The authors emphasize the importance of this fact due to its relation to side-effects which are often seen in the treatment with benzodiazepine tranquilizers. It has been concluded that adaptol may be used in the treatment of ADHD as a monotherapy in cases with predominance of hyperactivity/impulsivity and as a complex therapy in other diseases especially in the combination of ADHD and anxiety disorders.
已对一种非苯二氮䓬类镇静剂阿得妥在治疗注意力缺陷多动障碍(ADHD)方面的有效性进行了研究。每天两次服用500毫克阿得妥,持续一个月,结果显示多动和冲动行为减少,且对注意力和反应时间没有任何影响。作者强调了这一事实的重要性,因为它与苯二氮䓬类镇静剂治疗中常见的副作用有关。得出的结论是,阿得妥可用于治疗ADHD,在以多动/冲动为主的病例中作为单一疗法,在其他疾病中作为综合疗法,尤其是在ADHD与焦虑症合并的情况下。